Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Addus Homecare Corp (ADUS) today. The company’s shares opened today at $66.52.
According to TipRanks.com, Wiederhorn is a top 100 analyst with an average return of 14.4% and a 66.4% success rate. Wiederhorn covers the Services sector, focusing on stocks such as Cross Country Healthcare, Community Health, and The Ensign Group.
Addus Homecare Corp has an analyst consensus of Strong Buy, with a price target consensus of $75, implying a 12.7% upside from current levels. In a report issued on March 5, Jefferies also reiterated a Buy rating on the stock with a $75 price target.
See today’s analyst top recommended stocks >>
Based on Addus Homecare Corp’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $4.8 million. In comparison, last year the company had a net profit of $3.24 million.
Based on the recent corporate insider activity of 30 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health.
